Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity-Reference-Cited by-同舟云学术

Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity

Published:2019-06-25 Issue:1 Volume:4 Page:
ISSN:2059-0105
Container-title:npj Vaccines
language:en
Short-container-title:npj Vaccines

Author:

Bidet Katell,Ho Victor,Chu Collins Wenhan,Naim Ahmad Nazri Mohamed,Thazin Khaing,Chan Kuan Rong^ORCID,Low Jenny G. H.^ORCID,Choy Milly M.,Wong Lan Hiong,Florez de Sessions Paola,Lee Yie Hou^ORCID,Hibberd Martin L.,Ooi Eng Eong,Fink Katja^ORCID,Chen Jianzhu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Link

http://www.nature.com/articles/s41541-019-0119-3.pdf

Reference46 articles.

1. Rothman, A. L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 11, 532–543, https://doi.org/10.1038/nri3014 (2011).

2. Cerny, D. et al. Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog. 10, e1004548, https://doi.org/10.1371/journal.ppat.1004548 (2014).

3. Duyen, H. T. L. et al. Skin dendritic cell and T cell activation associated with dengue shock syndrome. Sci. Rep. 7, 14224, https://doi.org/10.1038/s41598-017-14640-1 (2017).

4. St John, A. L., Abraham, S. N. & Gubler, D. J. Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat. Rev. Microbiol. 11, 420–426, https://doi.org/10.1038/nrmicro3030 (2013).

5. Teoh, E. P. et al. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl. Med. 4, 139ra183, https://doi.org/10.1126/scitranslmed.3003888 (2012).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective;Frontiers in Microbiology;2024-08-20

2. Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy;Advanced Science;2024-08-08

3. TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview;Frontiers in Microbiology;2023-12-21

4. Long-acting vaccine delivery systems;Advanced Drug Delivery Reviews;2023-07

5. Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern;ACS Infectious Diseases;2022-06-24